Perimeter Medical Imaging AI Inc. has appointed veteran medtech sales executive Adam Hodges as vice president, sales and marketing. Perimeter is based in both Dallas and Toronto.
Perimeter Medical Imaging AI aims to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need.
“I am excited to welcome Adam to the Perimeter team as our senior leader responsible for the strategy and execution of our sales-related goals. Adam’s extensive medtech background represents a great fit, with his focus on advancing category-first, novel technologies that challenge the clinical standard of care and add value to the healthcare system,” Perimeter CEO Adrian Mendes said in a statement.
“We believe our market development managers and other team members in the field will benefit from his leadership as we expand the number of surgeon champions and geographical regions adopting our commercially available S-Series OCT medical imaging platform.”
Mendes said he expects Hodges will play an instrumental role in the expansion and adoption of Perimeter’s next-gen AI-enabled B-Series technology—currently in development—when it is ready for commercial roll-out.
The breakthrough-device designated investigational Perimeter B-Series OCT with ImgAssist AI represents the company’s next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to $7.4 million awarded by the Cancer Prevention and Research Institute of Texas.
Available across the U.S., the FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level.
Extensive expertise in medical device sales
Perimeter said that Hodges brings more than 20 years of commercialization experience in the medical device industry to his new post.
Most recently, he was vice president of sales at SIA Health, leading the commercial acceleration of DuraSorb, which was acquired by Integra LifeSciences in December 2022. During his tenure at SIA, Hodges grew sales revenue by more than 5X in less than two years and previously served concurrent roles of vice president of strategic accounts and regional business director, Perimeter said.
Before that, Hodges was VP of strategic accounts for Vapotherm, driving core commercial acceleration and identifying and growing adjacent markets for a novel respiratory therapy technology.
From 2009 to 2019, Hodges worked at Medtronic in various roles, including director of strategic accounts, senior regional business director, and account manager.
Early in his career, Hodges was an executive surgical device specialist for United States Surgical (Covidien/Medtronic) and a sales representative for Johnson & Johnson.
He began his career in 1998 as a change management consultant for Accenture.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.